Mar 20, 2020 / 10:30AM GMT
Operator
Ladies and gentlemen, good day and welcome to the discussion on impact of COVID-19. We have with us today on the call Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head Finance; Mr. Ajay Kumar Desai, Senior VP, Finance. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Pranav Amin. Thank you, and over to you, sir.
Pranav Chirayu Amin - Alembic Pharmaceuticals Limited - MD & Executive Director
Thank you. Good afternoon, everyone, and thank you all for joining our conference call. The reason for this is that we had multiple requests for a call about this topic and Alembic and the pharmaceutical outlook. And instead of individual calls, we thought we will just do one, where we address all of you together.
Before I get to the COVID pandemic, let me address the FDA issue that we recently had at F1, our main formulation plant for the U.S. and the European markets. We had 2 auditors who spent a
Alembic Pharmaceuticals Limited - Special Call Transcript
Mar 20, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers